A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To compare the time to progression of Cytomegalovirus (CMV) retinitis among each of three
doses of oral ganciclovir, as well as to intravenous therapy, when given as maintenance for
26 weeks. To compare the safety and tolerance among oral doses of ganciclovir at the study
doses, as well as to intravenous therapy, when administered as maintenance for 26 weeks.